Ultrasound imaging of the liver and bile ducts – expectations of a clinician

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al.: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005–2023.10.1002/hep.25762 Search in Google Scholar

2. Schwenzer NF, Springer F, Schram C, Stefan N, Machann J, Schick F: Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445.10.1016/j.jhep.2009.05.023 Search in Google Scholar

3. Sasso M, Miette V, Sandrin L, Beaugrand M: The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroScan. Clin Res HepatolGastroenterol 2012; 36: 13–20.10.1016/j.clinre.2011.08.001 Search in Google Scholar

4. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–1419.10.1016/S0016-5085(99)70506-8 Search in Google Scholar

5. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001; 344: 495–500.10.1056/NEJM20010215344070611172192 Search in Google Scholar

6. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases: Liver biopsy. Hepatology 2009; 49: 1017–1044.10.1002/hep.2274219243014 Search in Google Scholar

7. Tobari M, Hashimoto E, Yatsuji S, Torii N, Shiratori K: Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 2009; 48: 739–746.10.2169/internalmedicine.48.186919443967 Search in Google Scholar

8. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD: Non-invasive means of measuring hepatic fat content. World J Gastroenterol 2008; 14: 3476–3483.10.3748/wjg.14.3476271660818567074 Search in Google Scholar

9. Gerstenmaier JF, Gibson RN: Ultrasound in chronic liver disease. Insights Imaging 2014; 5: 441–455.10.1007/s13244-014-0336-2414134324859758 Search in Google Scholar

10. Walas MK, Skoczylas K, Gierbliński I: Standards of the Polish Ultrasound Society – update. The liver, gallbladder and bile ducts examinations. J Ultrason 2012; 12: 428–445.10.15557/JoU.2012.0031460323926673807 Search in Google Scholar

11. Bohte AE, van Werven JR, Bipat S, Stoker J: The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. EurRadiol 2011; 21: 87–97.10.1007/s00330-010-1905-5299587520680289 Search in Google Scholar

12. Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB: Sonographichepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound 2013; 41: 18–25.10.1002/jcu.2199422997020Search in Google Scholar

13. Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK: Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. Am J Roentgenol 2012; 199: 997–1002.10.2214/AJR.11.667723096171 Search in Google Scholar

14. Martín-Rodríguez JL, Arrebola JP, Jiménez-Moleón JJ, Olea N, González-Calvin JL: Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J GastroenterolHepatol 2014; 26: 88–94.10.1097/MEG.0b013e328365065023921844 Search in Google Scholar

15. Shen F, Zheng RD, Mi TQ, Wang XY, Pan Q, Chen GY et al.: Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 2014; 20: 4702–4711.10.3748/wjg.v20.i16.4702400050624782622 Search in Google Scholar

16. Kim JK, Lee KS, Choi JR, Chung HJ, Jung da H, Lee KA et al.: Usefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examinees. Gut Liver 2015; 9: 405–410.10.5009/gnl14202441397525717046 Search in Google Scholar

17. Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim do Y et al.: Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2014; 34: 102–109.10.1111/liv.1228224028214 Search in Google Scholar

18. Marrero JA, Ahn J, Rajender Reddy K; American College of Gastroenterology: ACG Clinical Guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109: 1328–1347.10.1038/ajg.2014.21325135008 Search in Google Scholar

19. Marin D, Furlan A, Federle MP, Midiri M, Brancatelli G: Imaging approach for evaluation of focal liver lesions. ClinGastroenterolHepatol 2009; 7: 624–634.10.1016/j.cgh.2009.03.02419348962 Search in Google Scholar

20. Robinson PJ: Imaging liver metastases: current limitations and future prospects. Br J Radiol 2000; 73: 234–241.10.1259/bjr.73.867.1081703710817037 Search in Google Scholar

21. Hohmann J, Albrecht T, Hoffmann CW, Wolf KJ: Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 2003; 46: 147–159.10.1016/S0720-048X(02)00053-0 Search in Google Scholar

22. Larcos G, Sorokopud H, Berry G, Farrell GC et al.: Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. Am J Roentgenol 1998; 171: 433–435.10.2214/ajr.171.2.9694470 Search in Google Scholar

23. Karhunen PJ: Benign hepatic tumours and tumour like conditions in men. J ClinPathol 1986; 39: 183–188.10.1136/jcp.39.2.183 Search in Google Scholar

24. Leen E, Becker D, Bolondi L, Steinbach R, Weskott H, Stacul F et al.: Prospective, open-label, multi-centre study evaluating the accuracy of unenhanced versus SonoVue^®enhanced ultrasonography in the characterization of focal liver lesions. Ultrasound Med Biol 2003; 29: 1–12.10.1016/S0301-5629(03)00148-0 Search in Google Scholar

25. Harvey CJ, Albrecht T: Ultrasound of focal liver lesions. EurRadiol 2001; 11: 1578–1593.10.1007/s00330010100211511877 Search in Google Scholar

26. Guang Y, Xie L, Ding H, Cai A, Huang Y: Diagnosis value of focal liver lesions with SonoVue^®-enhanced ultrasound compared with contrast- enhanced computed tomography and contrast-enhanced MRI: a metaanalysis. J Cancer Res ClinOncol 2011; 137: 1595–1605.10.1007/s00432-011-1035-821850382 Search in Google Scholar

27. Torzilli G: Adverse effects associated with SonoVue use. Expert Opin Drug Saf 2005; 4: 399–401.10.1517/14740338.4.3.39915934848 Search in Google Scholar

28. Juszczyk J, Boron-Kaczmarska A, Cianciara J, Flisiak R, Gladysz A, Ha- lota W et al.: Zaleceniaterapeutycznenarok 2013: leczenieprzeciw- wirusoweprzewlekłego wirusowegozapalenia wątroby typu B. PrzeglEpidemiol 2013; 67: 383–391. Search in Google Scholar

29. EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol 2015; 63: 199–236. Available from: www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf.10.1016/j.jhep.2015.03.02525911336 Search in Google Scholar

30. Ellis EL, Mann DA: Clinical evidence for the regression of liver fibrosis. J Hepatol 2012; 56: 1171–1180.10.1016/j.jhep.2011.09.02422245903 Search in Google Scholar

31. Berzigotti A, Castera L: Update on ultrasound imaging of liver fibrosis. J Hepatol 2013; 59: 180-182.10.1016/j.jhep.2012.12.02823333447 Search in Google Scholar

32. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology: Prevention and management of gastroesophagealvarices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922–938.10.1002/hep.2190717879356 Search in Google Scholar

33. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer: EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2012; 56: 1430.10.1016/j.jhep.2012.03.006 Search in Google Scholar

34. Choong CC, Venkatesh SK, Siew EP: Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci 2012; 2: 58.10.4103/2156-7514.101000351592823230540 Search in Google Scholar

35. Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D: Severe liver fibrosis or cirrhosis: accuracy of US for detection – analysis of 300 cases. Radiology 2003; 227: 89–94.10.1148/radiol.227202019312601199 Search in Google Scholar

36. KCS, Sharma D, Chataut SP: Hepatic vein waveforms in liver cirrhosis re-evaluated. HepatolInt 2011; 5: 581–585.10.1007/s12072-010-9226-y303400021442056 Search in Google Scholar

37. Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM et al.: Metaanalysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 2013; 33: 1138–1147.10.1111/liv.1224023859217 Search in Google Scholar

38. Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C et al.: Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 2012; 56: 2125–2133.10.1002/hep.2593622767302 Search in Google Scholar

39. Linguraru MG, Sandberg JK, Jones EC, Petrick N, Summers RM: Assessing hepatomegaly: automated volumetric analysis of the liver. AcadRadiol 2012; 19: 588–598.10.1016/j.acra.2012.01.015331928322361033 Search in Google Scholar

40. Talley NJ, O’Connor S: Clinical Examination: A Systematic Guide to Physical Diagnosis. Churchill Livingstone Elsevier, Sydney 2007. Search in Google Scholar

41. Douglas G, Nicol F, Robertson C: Macleod’s Clinical Examination. Churchill Livingstone Elsevier, Edinburgh 2009. Search in Google Scholar

42. Tchelepi H, Ralls PW, Radin R, Grant E: Sonography of diffuse liver disease. J Ultrasound Med 2002; 21: 1023–1032.10.7863/jum.2002.21.9.102312216750 Search in Google Scholar

43. Giorgio A, Amoroso P, Fico P, Lettieri G, Finelli L, de Stefano G et al.: Ultrasound evaluation of uncomplicated and complicated acute viral hepatitis. J Clin Ultrasound 1986; 14: 675–679.10.1002/jcu.18701409033098787 Search in Google Scholar

44. Krishnan M, Middleton WD: Ultrasonographic evaluation of right upper quadrant pain in emergency departments. Ultrasound Clin 2011; 6: 149–161.10.1016/j.cult.2011.03.004 Search in Google Scholar

45. Yarmish GM, Smith MP, Rosen MP, Baker ME, Blake MA, Cash BD et al.: American College of Radiology Appropriateness Criteria: RUQ Pain. J Am CollRadiol 2014; 11: 316–322. Search in Google Scholar

46. Ahmed F, Fogel EL: Right upper quadrant pain and a normal abdominal ultrasound. ClinGastroenterolHepatol 2008; 6: 1198–1201.10.1016/j.cgh.2008.06.02018995213 Search in Google Scholar

47. Yarmenitis SD: Ultrasound of the gallbladder and the biliary tree. EurRadiol 2002; 12: 270–282.10.1007/s00330-001-1251-811870422 Search in Google Scholar

48. Rubens DJ: Ultrasound imaging of the biliary tract. Ultrasound Clin 2007; 2: 391–413.10.1016/j.cult.2007.08.007 Search in Google Scholar

49. Rumack CM, Wilson SR, CharboneauJW, Levine D (eds.): Diagnostic Ultrasound. Vol. 1, Mosby, St. Louis 2011. Search in Google Scholar

50. Hunt DR: Common bile duct stones in non-dilated bile ducts? An ultrasound study. AustralasRadiol 1996; 40: 221–222.10.1111/j.1440-1673.1996.tb00389.x8826721Search in Google Scholar